---
category: news
title: "AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation"
excerpt: "Now, itâ€™s going public in the hope of getting more of its antibody work, which includes areas outside of COVID-19, out to partners."
publishedDateTime: 2020-12-07T13:58:00Z
originalUrl: "https://www.fiercebiotech.com/biotech/abcellera-tapped-by-lilly-for-its-covid-antibody-therapy-sets-ipo-terms-5b-valuation"
webUrl: "https://www.fiercebiotech.com/biotech/abcellera-tapped-by-lilly-for-its-covid-antibody-therapy-sets-ipo-terms-5b-valuation"
type: article
quality: 27
heat: 27
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1607352213/Nasdaq-Tower_092614_B.jpg/Nasdaq-Tower_092614_B.jpg?.I9s4nuPOUrPJX3KQtj7p3puS_n83t7S"
    width: 2400
    height: 1600
    isCached: true

secured: "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;AQl5HgBOnvKxqb0fd0axfA=="
---

